Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | REN | P00797 | 10/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30731556 | 0.95 | REN (0.48) | OPRM1RENACEF2CPB2 | |
| SCHEMBL29777729 | 0.90 | REN (0.48) | OPRM1RENACEF2 | |
| SCHEMBL30445980 | 0.89 | CAPN1 (0.41) | OPRM1REN | |
| SCHEMBL29588517 | 0.87 | ACE (0.52) | RENACE | |
| SCHEMBL29962469 | 0.87 | REN (0.44) | OPRM1RENACEF2 | |
| SCHEMBL29669249 | 0.87 | REN (0.45) | OPRM1RENF2 | |
| SCHEMBL31399255 | 0.86 | REN (0.44) | OPRM1RENF2 | |
| SCHEMBL29658176 | 0.85 | GRB2 (0.44) | OPRM1RENF2 | |
| SCHEMBL29801982 | 0.85 | REN (0.48) | RENACEF2 | |
| SCHEMBL31519059 | 0.85 | OPRM1 (0.57) | OPRM1REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | TYR, CUTA, ARGLU1 | OPRM1 3979/4885REN 1937/4885ACE 3524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.